Royal Bank Of Canada Matinas Bio Pharma Holdings, Inc. Transaction History

Royal Bank Of Canada

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.15 - $0.37 $450 - $1,110	-3,000 Reduced 28.76%	7,431 $1,000
Q1 2024 Nov 05, 2024	BUY	$0.19 - $0.3 $570 - $900	3,000 Added 40.37%	10,431 $2,000
Q1 2024 May 15, 2024	BUY	$0.19 - $0.3 $609 - $962	3,209 Added 44.43%	10,431 $2,000
Q4 2023 Feb 14, 2024	SELL	$0.12 - $0.64 $32 - $171	-268 Reduced 3.58%	7,222 $1,000
Q3 2023 Nov 14, 2023	BUY	$0.12 - $0.41 $42 - $143	350 Added 4.9%	7,490 $0
Q2 2023 Aug 14, 2023	SELL	$0.35 - $0.72 $158 - $326	-454 Reduced 5.98%	7,140 $2,000
Q1 2023 May 15, 2023	BUY	$0.39 - $0.6 $62 - $95	159 Added 2.14%	7,594 $3,000
Q4 2022 Feb 14, 2023	SELL	$0.46 - $42.69 $178 - $16,563	-388 Reduced 4.96%	7,435 $3,000
Q3 2022 Nov 14, 2022	BUY	$0.63 - $33.0 $174 - $9,141	277 Added 3.67%	7,823 $5,000
Q2 2022 Aug 15, 2022	SELL	$0.63 - $0.96 $3,545 - $5,402	-5,628 Reduced 42.72%	7,546 $6,000
Q1 2022 May 16, 2022	BUY	$0.5 - $1.06 $3,017 - $6,396	6,034 Added 84.51%	13,174 $11,000
Q4 2021 Feb 14, 2022	SELL	$0.92 - $1.22 $5,796 - $7,686	-6,300 Reduced 46.88%	7,140 $7,000
Q3 2021 Nov 15, 2021	BUY	$0.67 - $1.51 $4,221 - $9,513	6,300 Added 88.24%	13,440 $17,000
Q2 2021 Aug 16, 2021	BUY	$0.75 - $1.1 $5,355 - $7,854	7,140 New	7,140 $6,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.